Teladoc Health (NYSE:TDOC) Posts Earnings Results

Teladoc Health (NYSE:TDOC) posted its quarterly earnings data on Wednesday. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07), Zacks reports. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Teladoc Health updated its Q1 2025 guidance to -0.400–0.150 EPS and its FY 2025 guidance to -1.100–0.500 EPS.

Teladoc Health Price Performance

NYSE TDOC traded down $0.28 on Wednesday, hitting $10.91. The company had a trading volume of 10,466,903 shares, compared to its average volume of 8,008,443. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a market capitalization of $1.88 billion, a PE ratio of -1.89 and a beta of 1.04. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $15.95. The company’s fifty day moving average price is $10.58 and its 200-day moving average price is $9.52.

Analyst Ratings Changes

TDOC has been the subject of a number of research reports. Barclays lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Royal Bank of Canada increased their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. TD Cowen decreased their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research note on Thursday, October 31st. The Goldman Sachs Group raised their target price on shares of Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Tuesday, February 18th. Finally, Piper Sandler reiterated an “overweight” rating and set a $13.00 price objective (up previously from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. Thirteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Teladoc Health presently has an average rating of “Hold” and a consensus price target of $11.81.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.